206
Views
0
CrossRef citations to date
0
Altmetric
Research Report

Arylamine N-Acetyltransferase Gene Polymorphisms: Markers for Atopic Asthma, Serum IgE and Blood Eosinophil Counts

, &
Pages 673-682 | Published online: 03 Aug 2006

Bibliography

  • Frieri M : Asthma concepts in the new millennium: update in asthma pathophysiology.Allergy Asthma Proc.26(2), 83–88 (2005).
  • Maddox L , SchwartzDA: The pathophysiology of asthma.Annu. Rev. Med.53, 477–498 (2002).
  • Sengler C , LauS, WahnU, NickelR: Interactions between genes and environmental factors in asthma and atopy: new developments.Respir. Res.3, 7–22 (2002).
  • Kabesch M : Gene by environment interactions and the development of asthma and allergy.Toxicol. Lett.162(1), 43–48 (2006).
  • McCunney RJ : Asthma, genes, and air pollution.J. Occup. Environ. Med.47(12), 1285–1291 (2005).
  • Sharma S , MannD, SinghTP, GhoshB: Lack of association of histamine-N-methyltransferase (HNMT) polymorphisms with asthma in the Indian population.J. Hum. Genet.50(12), 611–617 (2005).
  • Fryer AA , BiancoA, HeppleM, JonesPW, StrangeRC, SpiteriMA: Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma.Am. J. Respir. Crit. Care Med.161, 1437–1442 (2000).
  • Mapp CE , FryerAA, De Marzo N et al.: Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J. Allergy Clin. Immunol.109, 867–872 (2002).
  • Vavilin VA , MakarovaSI, LiakhovichVV, GavalovSM: Polymorphic genes of xenobiotic-metabolizing enzymes associated with bronchial asthma in genetically predisposed children.Genetika38(4), 539–545 (2002).
  • Wikman H , PiirilaP, RosenbergC et al.: N-acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics12, 227–233 (2002).
  • Sorensen M , AutrupH, TjonnelandA, OvervadK, Raaschou-NielsenO: Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer.Cancer Lett.221(2), 185–190 (2005).
  • Hein DW , DollMA, RustanTD et al.: Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis14, 1633–1638 (1993).
  • Flammang TJ , KadlubarFF: Acetyl coenzyme A dependent metabolic activation of N-hydroxy-3, 2-dimethyl- 4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissues and species differences, other acyl donors and arylhydroxamic acid dependent acetyltransferases.Carcinogenesis7, 926–929 (1986).
  • Mattano SS , LandS, KingCM, Weber WW: Purification and biochemical characterization of hepatic N-acetyltransferase from rapid and acetylator mice: identity with arylhydroxamic acid N, O-acetyltransferase and N hydroxylamine O-acetyltransferase. Mol. Pharmacol.35, 599–609 (1989).
  • Fretland AJ , DollMA, GrayK, FengY, HeinDW: Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.Toxicol. Appl. Pharmacol.142(2), 360–366 (1997).
  • Hein DW , DollMA, FretlandAJ et al.: Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomark. Prev.9, 29–42 (2000).
  • Franke S , KlawitzI, SchnakenbergE et al.: Isolation and mapping of a cosmid clone containing the human NAT2 gene. Biochem. Biophys. Res. Commun.199, 52–55 (1994).
  • Hickman D , RischA, BuckleV et al.: Chromosomal localisation of human genes for arylamine N-acetyltransferase. Biochem. J.297, 441–445 (1994).
  • Hein DW , GrantDM and Sim E: Update on consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenetics10, 1–2 (2000).
  • Pawlik A , OstanekL, BrzoskoI et al.: Increased genotype frequency of N-acetyltransferase 2 slow acetylation patients with rheumatoid arthritis. Clin. Pharmacol. Ther.72, 319–325 (2002).
  • Yalin S , HatungilR, TamerL et al.: N-acetyltransferase 2 polymorphism in patients with diabetes mellitus. Cell Biochem. Funct.[Epub ahead of print] (2006).
  • Hein DW : N-acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis.Toxicol. Lett.112–113, 349–356 (2000).
  • Debiec-Rychter M , LandSJ, KingCM: Histological localization of acetyltransferases in human tissue.Cancer Lett.143(2), 99–102 (1999).
  • Mace K , BowmanED, VautraversP, Shields PG, Harris CC, Pfeifer AM: Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer34(6), 914–920 (1998).
  • Makarova SI , VavilinVA, LyakhovichVV, GavalovSM: Allele NAT2*5 determines resistance to bronchial asthma in children.Bull. Exp. Biol. Med.129(6), 575–577 (2000).
  • Nacak M , AynaciogluAS, FilizA et al.: Frequencies of arylamine N-acetyltransferase2 (NAT2) mutations in patients with bronchial asthma. Br. J. Clin. Pharmacol.54, 671–674 (2002).
  • Luszawska-Kutrzeba T : NAT2* genotype in children with bronchial asthma and other atopic diseases.Ann. Acad. Med. Stetin.45, 109–121 (1999).
  • Gawronska-Szklarz B , Luszawska-Kutrzeba T, Czaja-Bulsa G, Kurzawski G: Relationship between acetylation polymorphism and risk of atopic diseases. Clin. Pharmacol. Ther.65(5), 562–569 (1999).
  • Zielinska E , NiewirowskiW, BodalskiJ, StanczykA, BolanowskiW, RebowskiG: Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases.Clin. Pharmacol. Ther.62, 635–642 (1997).
  • Chatterjee R , BatraJ, KumarA et al.: Interleukin-10 promoter polymorphisms and atopic asthma in North Indians. Clin. Exp. Allergy35(7), 914–919 (2005).
  • Doll MA , FretlandAJ, DeitzAC, HeinDW: Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification.Anal. Biochem.231(2), 413–420 (1995).
  • Barrett JC , FryB, MallerJ, DalyMJ: Haploview: analysis and visualization of LD and haplotype maps.Bioinformatics21(2), 263–265 (2005).
  • Sasieni PD : From genotypes to genes: doubling the sample size.Biometrics53(4), 1253–1261 (1997).
  • Stephens M , SmithNJ, DonnellyP: A new statistical method for haplotype reconstruction from population data.Am. J. Hum. Genet.68, 978–989 (2001).
  • Sham PC , CurtisD: Monte Carlo tests for associations between disease and alleles at highly polymorphic loci.Ann. Hum. Genet.59, 97–105 (1995).
  • Boutin-Forzano S , HammouY, GouitaaM, CharpinD: Air pollution and atopy.Allerg. Immunol.37(1), 11–16 (2005).
  • Nacak M , ErbagciZ, AynaciogluAS: Human arylamine N-acetyltransferase 2 polymorphism and susceptibility to allergic contact dermatitis.Int. J. Dermatol.45(3), 323–326 (2006).
  • Seiler N : Catabolism of polyamines.Amino Acids26(3), 217–233 (2004).
  • Fajardo I , UrdialesJL, PazJC, ChavarriaT, Sanchez-JimenezF, MedinaMA: Histamine prevents polyamine accumulation in mouse C57.1 mast cell cultures.Eur. J. Biochem.268(3), 768–773 (2001).
  • Endo Y : Elevation of histamine levels in rat and mouse tissues by the deacetylation of administered N-acetylhistamine.Eur. J. Pharmacol.60(4), 299–305 (1979).
  • Scheuch E , WalterR, HadasovaE, AmonI, SiegmundW: Influence of H2-receptor and proton pump inhibitors on some functions of the oxydative and conjugative drug metabolism.Pharmazie51(7), 493–497 (1996).
  • Sabbagh A , DarluP: SNP selection at the NAT2 locus for an accurate prediction of the acetylation phenotype.Genet. Med.8(2), 76–85 (2006).
  • Leff MA , FretlandAJ, DollMA, HeinDW: Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype.J. Biol. Chem.274(49), 34519–34522 (1999).
  • Anitha A , BanerjeeM. Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India. Int. J. Mol. Med.11(1), 125–131 (2003).
  • Bouzigon E , DizierMH, KrahenbuhlC et al.: Clustering patterns of LOD scores for asthma-related phenotypes revealed by a genome-wide screen in 295 French EGEA families. Hum. Mol. Genet.13(24), 3103–3113 (2004).

Websites

  • TDT/S-TDT program from the Spielman laboratory. http://genomics.med.upenn.edu/spielman/TDT.htm
  • FINETTI program webpage. http://ihg.gsf.de/cgi-bin/hw/hwa1.pl
  • The Laboratory of Statistical Genetics at Rockefeller University website. http://linkage.rockefeller.edu/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.